6 results
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... ., concomitant medications ... ) for 1–4 doses ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... months or • RFB (dose ... #Prevention #Treatment ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... Indications: ... (Varivax™), 2 doses ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
for Preventing ... in HIV-AIDS Indications ... with ARV (see Table ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Prophylaxis): Indications ... please refer to Table ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
adjusting the dose ... acute coronary syndrome ... the determined cause ... #management #cardiology ... #treatment #table